• Hematology (systemic fungal infections, essential thrombocythemia, bone marrow transplantation, multiple myeloma)
  • Neonatology (respiratory distress syndrome in premature newborns, primary apnea)
  • Pulmonology (pulmonary arterial hypertension, cystic fibrosis, asthma, acute respiratory distress syndrome)
  • Anesthesia and intensive care (general and regional anesthesia, opiate overdose, pain control, postoperative nausea and vomiting)
  • Neurology (Hungtington’s chorea)
  • Cardiology (unstable angina, myocardial infarction, supraventricular tachycardia)
  • Gynecology (fungal and bacterial infections)
  • Psychiatry (opioid and alcohol addiction, schizophrenia)
  • Gastroenterology (cystic fibrosis, bowel disorders)
  • Oncology (medical devices for safety handling of cytostatics and hazardous drugs)

Current Providens Portfolio consists of: 

  • Orphan pharmaceuticals - 7
  • Innovative pharmaceuticals
  • Hospital generics


Providens obtained  67 Marketing Authorizations within our Territory.